Montreal Heart Institute
Montreal, Quebec, H1T 1C8, Canada
NCT Number: NCT00834691
Anemia is frequent in patients with heart failure. Few studies have clearly addressed the causes of anemia in patients with HF. The purpose of this study is to evaluate differences in blood concentrations of various substances related to inflammation, oxidative stress, renal function and other processes between individuals with 1) heart failure and anemia, 2) heart failure without anemia and 3) patients with kidney disease without systolic heart failure. This study will help to better understand the reasons why some people with heart failure have anemia.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Montreal, Quebec, H1T 1C8, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Groups 1 and 2
Inclusion criteria
- group 3
Exclusion criteria
(all groups):
Time frame: Visit 2 (within 2 weeks of baseline visit)
Time frame: Visit 2 (within 2 weeks of baseline visit)
Montreal Heart Institute
Other
Anemia in Chronic Heart Failure: Etiology, Comparisons With Renal Disease, and Relationships With Biomarkers and Left Ventricular Remodeling.
Acronym: ANCHOR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07708025
Anemia, Cardiovascular Diseases
Porto, Portugal
View Trial DetailsNCT06227819
Anemia, Cardiovascular Diseases
Oak Ridge, Tennessee, United States
View Trial DetailsNCT00358215
Anemia, Cardiovascular Disease
Birmingham, Alabama, United States
View Trial DetailsNCT03847753
Acquired Immunodeficiency Syndrome, Allergy
View Trial Details